시장보고서
상품코드
1794615

세계의 말초혈관 진단 시스템 시장

Peripheral Vascular Diagnostic Systems

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 185 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말초혈관 진단 시스템 세계 시장은 2030년까지 6억 4,020만 달러에 달할 전망

2024년에 4억 4,730만 달러로 추정되는 말초혈관 진단 시스템 세계 시장은 2024년부터 2030년까지 CAGR 6.2%로 성장하여 2030년에는 6억 4,020만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 병원·진료소 최종사용은 CAGR 5.8%를 기록하며 분석 기간 종료시에는 3억 7,890만 달러에 달할 것으로 예측됩니다. 외래 수술 센터(Ambulatory Surgery Centers End-Use) 부문의 성장률은 분석 기간 동안 CAGR 7.0%로 추정됩니다.

미국 시장은 1억 2,190만 달러로 추정, 중국은 CAGR 9.6%로 성장 예측

미국의 말초혈관 진단 시스템 시장은 2024년에 1억 2,190만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 1억 3,040만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.1%와 6.0%로 예측됩니다. 유럽에서는 독일이 CAGR 4.0%로 성장할 것으로 예측됩니다.

세계의 말초혈관 진단 시스템 시장 - 주요 동향과 촉진요인 정리

왜 말초혈관 진단 시스템이 혈관질환 관리의 중심이 되고 있는가?

말초혈관 진단 시스템은 심장이나 뇌 이외의 동맥과 정맥의 장애를 감지하고 평가하는 데 사용됩니다. 이 시스템은 말초동맥질환(PAD), 만성정맥부전, 심부정맥혈전증, 동맥류 진단에 도움이 됩니다. 당뇨병, 흡연, 좌식 생활습관 등으로 혈관질환의 세계적 부담이 증가하고 있는 가운데, 사지 허혈, 뇌졸중 등의 합병증을 예방하기 위해서는 정확하고 빠른 진단이 필수적입니다.

이러한 시스템에는 일반적으로 도플러 초음파, 족관절-팔뚝 혈압비(ABI) 측정 도구, 전산화단층촬영, 고급 영상 진단 기법이 포함됩니다. 외래 진료소, 혈관 연구소, 일차 진료 시설에 통합되어 접근성이 향상되고, 보다 일상적인 검진이 가능해졌습니다. PAD가 전신성 죽상동맥경화증의 조기 표지자라는 인식이 높아지면서 예방심장병학에서 혈관 진단의 역할이 증가하고 있습니다.

기술의 발전은 어떻게 정확도와 임상적 유용성을 높이고 있는가?

비침습적 진단 시스템은 현재 조기 질병에 대한 민감도를 향상시켜 보다 신속하고 정확한 결과를 제공하고 있습니다. 고해상도 프로브가 장착된 휴대용 도플러 초음파 시스템, 자동 ABI 측정 장치, 실시간 혈류 모니터링 도구는 환자의 불편함을 최소화하면서 신속한 평가를 가능하게 합니다. 인공지능을 영상 진단 플랫폼에 통합함으로써 임상의가 보다 효율적으로 결과를 해석하고 진단의 편차를 줄일 수 있도록 돕고 있습니다.

ABI, 맥박수 기록, 듀플렉스 초음파를 결합한 멀티모달 진단 장비가 개발되어 한 번의 검사로 종합적인 평가를 할 수 있게 되었습니다. 첨단 의료센터에서는 디지털 혈관 영상 시스템이 기능적, 해부학적 정보를 제공하여 치료 전 계획 수립에 도움을 주고 있습니다. 원격의료에 대응하는 장비와 클라우드 기반 진단 플랫폼이 등장하고 있으며, 특히 의료서비스가 부족한 지역에서 원격 환자 평가를 지원하고 있습니다.

도입이 확대되고 있는 곳은 어디이며, 어떤 시설이 수요를 주도하고 있는가?

진단 시스템은 혈관 수술 센터, 외래 진료소, 순환기과에서 널리 사용되고 있습니다. 일차 진료 의사들도 위험에 처한 환자를 조기에 발견하기 위해 기본적인 ABI 스크리닝 도구를 채택하고 있습니다. 북미와 유럽은 이미 확립된 진료 보상 체계와 공중보건 검진 프로그램에 힘입어 도입에 앞장서고 있습니다. 아시아태평양에서는 생활습관 관련 혈관 질환의 증가와 전문 진단 센터의 확대로 인해 이용이 증가하고 있습니다.

병원에서는 응급 상황이나 수술 전 위험 평가를 효율적으로 하기 위해 휴대용 혈관 진단 도구에 투자하고 있습니다. 외래 및 지역 의료 현장에서는 휴대용 ABI 시스템이 신속한 PAD 스크리닝을 위해 사용되고 있습니다. 당뇨병 환자의 혈관 합병증에 대한 일반의와 내분비 전문의의 인식이 높아짐에 따라, 진단 솔루션에 대한 수요는 도시와 지방을 막론하고 확대되고 있습니다.

말초혈관 진단 시스템 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

말초혈관 진단 시스템 시장의 성장은 말초혈관 질환의 유병률 증가, 비침습적 진단 도구의 기술 발전, 위험 집단에 대한 스크리닝 이니셔티브의 확대 등의 요인에 의해 주도될 것으로 예상됩니다. 당뇨병 환자 및 노인 인구의 증가는 예방의학에서 ABI 및 도플러 기반 평가의 정기적인 사용을 촉진하고 있습니다.

휴대가 간편하고 사용하기 쉬운 진단 장비의 개발, AI를 활용한 영상 분석의 통합, 조기 개입에 대한 중요성 증가가 시장 개척을 촉진하고 있습니다. 일차 의료 서비스 제공자의 인식 개선은 외래 진단 인프라 및 디지털 헬스 플랫폼에 대한 투자와 함께 전 세계적으로 혈관 진단에 대한 접근성을 확대하는 데 기여하고 있습니다.

부문

최종사용자(병원·클리닉, 외래 수술 센터, 의사 오피스)

조사 대상 기업 사례

  • Abbott
  • ADInstruments
  • AngioDynamics
  • B. Braun Melsungen AG
  • Biopac Systems Inc.
  • Canon Medical Systems Corp
  • Carestream Health
  • Compumedics Limited
  • Cook Medical
  • ELCAT GmbH
  • Fukuda Denshi Co., Ltd.
  • GE HealthCare
  • Hitachi Medical Systems
  • KONINKLIJKE PHILIPS N.V.
  • Medtronic
  • MESI, Ltd.
  • Mindray Medical International
  • Natus Medical Incorporated
  • Siemens Healthineers
  • Vaso Corporation

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Peripheral Vascular Diagnostic Systems Market to Reach US$640.2 Million by 2030

The global market for Peripheral Vascular Diagnostic Systems estimated at US$447.3 Million in the year 2024, is expected to reach US$640.2 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$378.9 Million by the end of the analysis period. Growth in the Ambulatory Surgery Centers End-Use segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$121.9 Million While China is Forecast to Grow at 9.6% CAGR

The Peripheral Vascular Diagnostic Systems market in the U.S. is estimated at US$121.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$130.4 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Peripheral Vascular Diagnostic Systems Market - Key Trends & Drivers Summarized

Why Are Peripheral Vascular Diagnostic Systems Becoming Central to Vascular Disease Management?

Peripheral vascular diagnostic systems are used to detect and assess disorders in arteries and veins located outside the heart and brain. These systems help diagnose peripheral artery disease (PAD), chronic venous insufficiency, deep vein thrombosis, and aneurysms. As the global burden of vascular disease increases due to diabetes, smoking, and sedentary lifestyles, accurate and early diagnosis has become essential to prevent complications such as limb ischemia or stroke.

These systems typically include Doppler ultrasound, ankle-brachial index (ABI) measurement tools, plethysmography, and advanced imaging modalities. Integration into outpatient clinics, vascular labs, and primary care facilities is improving accessibility and enabling more routine screening. Growing recognition of PAD as an early marker of systemic atherosclerosis is increasing the role of vascular diagnostics in preventive cardiology as well.

How Are Technology Advancements Enhancing Accuracy and Clinical Usefulness?

Non-invasive diagnostic systems now offer faster, more accurate results with improved sensitivity for early-stage disease. Portable Doppler ultrasound systems with high-resolution probes, automated ABI measurement devices, and real-time blood flow monitoring tools are allowing quicker assessments with minimal patient discomfort. Integration of artificial intelligence into imaging platforms is helping clinicians interpret results more efficiently and reduce diagnostic variability.

Multimodal diagnostic units that combine ABI, pulse volume recording, and duplex ultrasound are being developed to offer comprehensive assessments in a single session. In advanced care centers, digital vascular imaging systems provide functional and anatomical information, assisting in pre-procedural planning. Telemedicine-compatible devices and cloud-based diagnostic platforms are emerging to support remote patient assessment, especially in underserved regions.

Where Is Adoption Expanding and Which Facilities Are Driving Demand?

Diagnostic systems are widely used in vascular surgery centers, outpatient clinics, and cardiology departments. Primary care physicians are also adopting basic ABI screening tools to identify at-risk patients early. North America and Europe lead in deployment, aided by established reimbursement structures and public health screening programs. Asia-Pacific is seeing increasing usage due to the rise in lifestyle-related vascular diseases and expansion of specialty diagnostic centers.

Hospitals are investing in portable vascular diagnostic tools to streamline emergency evaluations and pre-operative risk assessments. In ambulatory and community care settings, portable ABI systems are being used for rapid PAD screening. As awareness grows among general practitioners and endocrinologists about vascular complications in diabetic patients, demand for diagnostic solutions is expanding in both urban and rural settings.

Growth in the Peripheral Vascular Diagnostic Systems market is driven by several factors…

Growth in the peripheral vascular diagnostic systems market is driven by factors such as increasing prevalence of peripheral vascular disorders, technological advancements in non-invasive diagnostic tools, and expanding screening initiatives for at-risk populations. Rising diabetic and elderly populations are prompting regular use of ABI and Doppler-based assessments in preventive care.

Development of portable, user-friendly diagnostic devices, integration of AI-driven imaging analysis, and growing emphasis on early intervention are supporting market adoption. Improved awareness among primary care providers, combined with investment in outpatient diagnostic infrastructure and digital health platforms, is helping expand access to vascular diagnostics globally.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Diagnostic Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Physician Office End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott
  • ADInstruments
  • AngioDynamics
  • B. Braun Melsungen AG
  • Biopac Systems Inc.
  • Canon Medical Systems Corp
  • Carestream Health
  • Compumedics Limited
  • Cook Medical
  • ELCAT GmbH
  • Fukuda Denshi Co., Ltd.
  • GE HealthCare
  • Hitachi Medical Systems
  • KONINKLIJKE PHILIPS N.V.
  • Medtronic
  • MESI, Ltd.
  • Mindray Medical International
  • Natus Medical Incorporated
  • Siemens Healthineers
  • Vaso Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Vascular Diagnostic Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Peripheral Artery Disease (PAD) Spurs Demand for Early and Accurate Vascular Diagnostic Tools
    • Shift Toward Non-Invasive and Point-of-Care Testing Strengthens Adoption of Doppler, ABI, and Segmental Pressure Systems
    • Technological Advancements in Duplex Ultrasound and PPG Devices Enhance Precision and Real-Time Blood Flow Assessment
    • Growth in Geriatric and Diabetic Populations Throws the Spotlight on Routine PAD Screening and Surveillance
    • OEM Focus on Portable and Wireless Diagnostic Platforms Supports Use in Clinics, Mobile Units, and Remote Health Centers
    • Increased Emphasis on Early Detection of Asymptomatic Vascular Disease Drives Utilization in Primary Care Settings
    • Integration With EMR Systems and PACS Enhances Workflow Efficiency and Diagnostic Record Management
    • Expansion of Hybrid Imaging Solutions Combines Anatomical and Functional Analysis for Advanced Vascular Assessment
    • Growing Demand for Real-Time Monitoring in Interventional Procedures Supports Intraoperative Use of Vascular Imaging Tools
    • OEM Development of Multi-Modality Systems With AI Interpretation Capabilities Enhances Decision-Making in Complex Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Vascular Diagnostic Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Physician Office End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Physician Office End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Physician Office End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: China 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: France 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: India 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제